Clinical Study
Self-Reported Executive Functioning in Everyday Life in Parkinson’s Disease after Three Months of Subthalamic Deep Brain Stimulation
Table 2
Results of neurological measurements; Movement Disorder Society-Sponsored Revision of the Unified Parkinson’s Disease Rating Scale (MDS-UPDRS-III) motor scores, Hoehn and Yahr disease stage, and levodopa equivalent daily dose (LEDD) in mg preoperatively and at 3-month follow-up.
|